Finding appropriate doses for HER2 positive breast cancers

19:42 EDT 3 Jun 2018 | ecancermedicalscience

Dr MacGregor speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago about therapy escalation/deescalation for patients with HER2 positive breast cancer. She summarises the discussions from the session,...

Original Article: Finding appropriate doses for HER2 positive breast cancers

More From BioPortfolio on "Finding appropriate doses for HER2 positive breast cancers"